Fluoxetine (Prozac) Paroxetine (Paxil) Sertraline (Zoloft) Fluvoxamine (Luvox) Citalopram (Celexa)
|
|
- Hilda Amelia Rodgers
- 5 years ago
- Views:
Transcription
1 Pharmacology Overview for ASD & ADHD Robert L. Hendren, D.O. Professor and Vice Chair of Psychiatry, Director, Child and Adolescent Psychiatry UC San Francisco Disclosures Clinical Trials (past year) Forest Laboratories, Inc. Otsuka & Bristol Meyer Squibb Janssen NIMH Autism Speaks Disclosure All medication suggestions for the treatment of ASD in this presentation are off-label uses except for risperidone (Risperdal) and aripiprazole (Abilify). All of the medications discussed for the treatment of ADHD in children are FDA approved Neuromodulators Dopamine - regulation of attention, movement, reward dependence with extensive innervation in frontal lobe and basal ganglia Serotonin - sleep, appetite, impulsivity, mood with extensive innervations in the basal ganglia Norepinepherine - fear and anxiety, vigilance, selective attention, arousal, memory Glutamate - excitatory amino acid GABA- inhibitory amino acid 1
2 ASD Associated Target Symptoms Inattention Impulsivity/Compulsivity Affective Instability Cognitive Disorganization Anxiety/ Hyperarousal Symptoms and Psychotropic Medications Distractible inattention improves with stimulants (dopamine, norepinepherine) Impulsivity improves with SSRIs (serotonin) Affective instability improves with mood stabilizers (glutamate, GABA) Cognitive disorganization improves with atypical neuroleptics (dopamine, serotonin) Hyperarousal improves with alpha adrenergic agonists (norepinepherine) (Sudgen et al., J Neuropsychiatry Clin Neurosci, 2006) Stimulant and Non-stimulants Symptoms - distractible inattention, conduct problems - Methylphenidate (Ritalin, Concerta Methylin, Metadate) - Dextroamphetamine (Dexedrine, Adderall) - Atomoxetine (Strattera) - Bupropion (Wellbutrin) Antidepressants Symptoms - anxiety, depression, impulsivity, obsessions, compulsions, irritability, easily frustrated & angry, separation anxiety, behavior problems. Fluoxetine (Prozac) Paroxetine (Paxil) Sertraline (Zoloft) Fluvoxamine (Luvox) Citalopram (Celexa) Escitalopram (Lexapro) Venlafaxine (Effexor) Duloxetine(Cymbalta) Bupropion (Wellbutrin) 2
3 Atypical Neuroleptics Symptoms - social awkwardness, inappropriateness, withdrawal, tics, obsessions, compulsions, disorganization, hallucinations, delusions, conduct problems. risperidone (Risperdal) aripiprazole (Abilify) quetiapine (Seroquel) ziprasidone (Geodon) olanzapine (Zyprexa) clozapine (Clozaril) Mood Stabilizers Symptoms - mood instability, temper tantrums, anger, depression, impulsivity. Valproic acid (Depakote, Depakane) Carbamazepine (Tegretol, Carbitrol, Trileptal) Lamotrigine (Lamictal) Lithium carbonate (Lithobid Lithobid, Lithostat) Gabapentin (Neurontin) Topiramate (Topamax) Tiagabine (Gabitril) Adrenergic Stimulating Agents Others Symptoms - anxiety, sleep disturbance, PTSD, hyperactivity, impulsivity Clonidine (Catapres) Guanfacine (Tenex) Buspirone (BuSpar) Anxiolytics (Alprazolam, Clonazepam, Lorazepam) Propranolol (Inderal) 3
4 Inattention Pharmacologic Approach to Target Symptom Impulsivity/ Compulsivity Anxious/ Hyperarousal Affective Instability Cognitive Disorganization Which Inattention? Distractible inattention (fronto-straital, dopamine) - stimulants Difficulty changing sets (cerebellum, basal ganglia, serotonin) SSRI, atypicals Low arousal (dopamine, serotonin) - Atypicals Hyper-Arousal vigilance (norepinepherine) anti-anxiety anxiety agents ADHD Pharmacological Response Stimulant Untoward Effects Methylphenidate Amphetamine TCAs Bupropion MAOIs Clonidine/ Psychosis Lower seizure threshold? Tachycardia, palpitations, hypertension (Gould, 2009) guanfacine Response Rate (%) Wilens TE (2001), CNS News, Spencer TJ (2004), J Clin Psychiatry 65(suppl 3):22-26; Spencer TJ (2004),J Clin Psychiatry 65(suppl 3):
5 Managing Adverse Effects From ADHD Treatment Decreased appetite Affects about 6-7% of children Monitor weight Administer with or after meals Give high-calorie snacks Consider drug holidays or cyproheptadine Growth suppresion Monitor weight Use lowest effective dose Drug holidays? Managing Adverse Effects From ADHD Treatment (Cont.) Insomnia (may be a manifestation of ADHD itself) If patient can nap on meds, add another dose Administer dose earlier in day or a small dose at bedtime Try longer-acting preparation Melatonin or Clonidine at bedtime Mirtazapine (Remeron) 7.5 mg or Trazedone (25 to 50 mg) at bedtime Avoid sedative/hypnotic medications Dulcan M (1997), J Am Acad Child Adolesc Psychiatry 36(10 suppl):85s-121s; Findling RL et al. (1998), J Clin Psychiatry 59(suppl 7):42-49 Dulcan M (1997), J Am Acad Child Adolesc Psychiatry 36(10 suppl):85s-121s; Findling RL et al. (1998), J Clin Psychiatry 59(suppl 7):42-49 Managing Adverse Effects From ADHD Treatment (Cont.) Tics (usually transient, only rarely do patients develop a chronic tic disorder) Medicolegal concern Many children with tics and ADHD can tolerate stimulants without an increase in tics Switch stimulants Try nonstimulant medication Rebound effects Smaller step-down afternoon dose Try longer-acting preparation Emerging Treatment Options Delivery Systems Daytrana - Methylphenidate transdermal system (MTS) (Findling et al., 2009) 10, 15, 20, 30 mg/ 9 hour patch Vyvanse - Lisdexamfetamine (L-lysine lysine-d-amphetamine) (prodrug of D-amphetamine) (Najib Najib, mg dissolves in liquid Dulcan M (1997), J Am Acad Child Adolesc Psychiatry 36(10 suppl):85s-121s; Findling RL et al. (1998), J Clin Psychiatry 59(suppl 7):
6 Nonstimulants: Atomoxetine (Strattera) Blocks presynaptic norepinepherine transporter with no significant dopamine effect Similar improvement in ADHD symptoms to methylphenidate, but perhaps less improvement in inattention Modest improvement in depression and anxiety if present Dosage: mg once/day Maybe of benefit to stimulant partial responders (Hammerness P, 2009, JCAP) Kratochvil CJ et al. (2002), J AACAP; Donnelly, C (2009) JAACAP Nonstimulants: Atomoxetine (Cont.) Adverse effects in children: decreased appetite, nausea, abdominal pain, dizziness, somnolence Adverse effects in adults: constipation, dry mouth, urinary retention and sexual dysfunction Possible decreased height and weight with longer term treatment Caution with poor CYP2D6 metabolizers FDA warnings: liver toxicity, suicidal thoughts in children Well tolerated in youth with ADHD and Bipolar (Chang K, 2009, JCAP) Brown University Child and Adolescent Psychopharmacology Update (2003), 5:1-8; Prescribing information. Available at: Unproven (but maybe effective) (but maybe effective)treatments EEG biofeedback training Dietary manipulation: oligoantigenic diet Megavitamin therapy Herbal treatments Manipulation: body and craniosacral Sensory integration training Antiyeast medications Supplements (acetyl carnitine, essential fatty acids, Ginko biloba) Stimulants and ASD Evidence for effectiveness mixed with less information for amphetamines Early studies suggest ineffectiveness and poor tolerability (Campbell, 1972, 1976) RUPP DBPC study (2005) of 72 youth using methylphenidate suggest improvement in some but with lower rates of improvement and more adverse events than in children with ADHD without ASD. Decrease in appetite; sudden cardiac death Atomoxetine-small studies suggest improvement but less than children with ADHD without ASD Arnold LE (2001), Ann N Y Acad Sci 931: ; Kidd PM (2000), Altern Med Rev 5(5):
7 Inattention Pharmacologic Approach to Symptom Domains Impulsivity/ Compulsivity Anxious/ Hyperarousal Affective Instability Cognitive Disorganization Impulsivity - Treatment Prolong thinking before action Educational and behavioral focus practicing delay, response inhibition, and reflection. CBT Removal from high-risk situations & strengthen cultural container Pharmacologic Interventions Stimulants SSRIs Mood stabilizers SSRI s and Autism Serotonin consistently shown to be disregulated in ASD (Cook, 1997). (Posey 2006; Henry 2006) Fluvoxamine and sertraline demonstrate improvement in aggression, and social relations (McDougle, 1996, 1998). Retrospective review of 15 children treated with citalopram reported improvement in anxiety and mood in 11 with mild side effects in 5 (Namerow, 2003) Perhaps improved language and correlation with family hx affective disorder (Delong, 2002) DBPC trial of fluoxetine in children found significant improvement in repetitive behaviors (Hollander, 2005) Lack of Efficacy of Citalopram for Repetitive Behaviors in ASD DBPC trial with 149 children (5 to 17 years) with ASD, mean dose 16.5 mg/da) No significant difference on CGI-I I or CY- BOCS Citalopram more likely to cause increased energy, impulsiveness, hyperactivity, decreased concentration, stereotypy, diarrhea and insomnia. 30% placebo response rate (King et al, 2009) 7
8 Inattention Pharmacologic Approach to Symptom Domains Impulsivity/ Compulsivity Anxious/ Hyperarousal Affective Instability Cognitive Disorganization Anxious Hyperarousal - Treatment Stress management Stress reduction Stress anticipation Pharmacologic interventions SSRIs Alpha adrenergic blockers (e.g. clonidine) Anxiolytics Tricyclics Alpha-2 Adrenergic Agonists Clonidine 2 DBPC (Jaselskis et al, 1992; Fankhauser et al, 1992) modest benefit for overactivity, sensory responses, affectual reactions and decreased irritability, stereotypy, and oppositional behavior Sedation, fatigue, decreased activity Guanfacine retrospective 80 ss with ASD; prospective 23 ss (Posey et al, 2004, Handan et al., 2008) decreased hyperactivity Sedation, constipation, sleep disruption, irritability Inattention Pharmacologic Approach to Symptom Domains Impulsivity/ Compulsivity Anxious/ Hyperarousal Affective Instability Cognitive Disorganization 8
9 Affective Instability - Treatment Strengthen the cognitive path from the perception of emotion to action CBT & DBT Pharmacologic Treatments Atypical neuroleptics (e.g. risperidone) Mood stabilizers (e.g. divalproex) Inhibit through GABA; inhibit glutamate Divalproex and ASD (inhibit through GABA) Retrospective review of 14 patients 5 to 40 years of age. 10 (71%) reported sustained, positive response to treatment. Mean dose 768 mg.da (range mg) Affective instability, impulsivity, and aggression most likely to respond. All with abnormal EEG responded. (Hollander, 2001) Repetitive behavior improved in DBPC study (Hollander, 2006) Topiramate and ASD (Inhibit glutamate) Retrospective review of 15 patients 8 to 18 years of age. 8 were judged to be responders with a score of 1 or 2 on the CGI-I Mean dose 235 mg.da (range mg) Conduct, hyperactivity and inattention most likely to respond. Side effects leading to discontinuation include cognitive difficulties and skin rash (Hardan, 2004) Inattention Pharmacologic Approach to Symptom Domains Impulsivity/ Compulsivity Anxious/ Hyperarousal Affective Instability Cognitive Disorganization 9
10 Cognitive Disorganization- Treatment Improve executive function and memory Social skills, behavioral interventions and CBT D2 blocking helps with positive symptoms 5-HT2A enhancers improve negative symptoms Pharmacologic interventions Neuroloptics Anxiolytics A Double-Blind Placebo Controlled Trial of Risperidone in Autistic Disorder 101 children between 5 and 17 years with AD and mental age > 18 mo. No other psychotropics. 8 weeks of treatment associated with statistically significant decrease in self-injury, aggression, agitation, sterotypy and hyperactivity. (McCracken, 2002) A Double-Blind Placebo Controlled Trial of Risperidone in Autistic Disorder - (cont.) Average weight gain of 2.5 kg after 8 weeks compared with.2 kg in placebo group. Mean dose 1.8 mg Other AEs include increased appetite, sedation, tremor and hypersalivation. No EPS or TD reported in longer term follow-up (Aman, 2005). Second double blind study completed (Shea et al., 2004) Aripiprazole in the Treatment of Irritability in Youth with Autism 8 week DBPC fixed and flexible dose study of over 300 children & adolescents 6 to 17 yrs 85% completion; Average dose 8.1mg; 50 52% responders based on ABC-I and CGI=I of much or very much improve Somnolence, sedation and drooling most common side effects. EPS 12 to 14% which was dose dependent; Weight gain.9 vs..5 kg placebo; curve flattens at 6 to 9 months Marcus RN (2009) JAACAP; Owen R (2009) Pediatrics 10
11 Olanzapine, Quetiapine, Ziprazidone Decreased temper tantrums, impulsivity, social withdrawal and autism symptoms including social relations and language but not repetitive behaviors (Potenza, 1999; Kemner, 2002, Masi, 2009). Olanzapine vs. haloperidol in children demonstrated CGI response in both, but broader response with olanzapine (Malone, 2001). Reviews suggest quetiapine useful and well tolerated (Findling, 2002) Ziprazidone shows modest improvement with weight loss (McDougle, 2002; Cohen 2004) Concern about rapid metabolic changes in children (Nicol, 2009) Rationale Memantine (Namenda) - Excitatory neurotransmitter glutamate may play a role in neurodegeneration mediated by NMDA. - Memantine is a low to moderate affinity, uncompetitive NMDA receptor antagonist - Aberrant functioning of NMDA receptor and/or altered glutamate may play a role in autism Evidence - Case series demonstrating significant improvement in language and socialization in children with autism. (Chez, 2006) - Open label, retrospective study of 18 patients, 6 to 19 years, 11 improved in social withdrawal and inattention at doses between 2.5 and 20 mg/day (Erickson et al., Psycopharmacology, 2007) Procedure - Titrate in 5 mg increments to 10 to 20 mg in divided BID dose Safety - Well tolerated in children. Some experience fatigue, modest increase in LFTs Melatonin for Sleep DBPC trial of 5 mg CR melatonin in 51 children, 2 18 years, found significant improvement in 30 min and improvement in family stress (Wasdell, 2008) Open trial of 3 mg in 15 children 6 to 17 years found excellent sleep response in half and improvement in behavioral measures (Paavonen et al., 2003) Naltrexone and Autism Modest improvements in self injurious behavior Moderate improvement in hyperactivity and restlessness (Desjardins, 2009) No improvement in core symptoms (Symons, 2004) Suggestion that low dose (2.5 mg/ day) may affect immune system and improve core symptoms (McCandless, personal communication) 11
12 The 12
Schedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationAlpha-2 Agonists. Antipsychotics
Table 5: Randomized Controlled Trials of Psychotropic Medications in Children and Adolescents with ASD Agent Study Target Symptoms Dose Demographics Significant Side Clonidine Guanfacine Jaselskis et al.,
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationChange Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness
Change Your Brain, Change Your Life The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Daniel G Amen Three Rivers Press New York Appendix Medication 1.
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationAutism: Improving Health Care Outcomes
AUTISM AWARESS CONFERENCE Lewis County Autism Coalition 23 September 2011 Autism: Improving Health Care Outcomes Glenn C. Tripp, M.D. Developmental Behavioral Pediatrics Medical Director, Developmental
More informationPsychopharmacology of Autism Spectrum Disorder
Psychopharmacology of Autism Spectrum Disorder Christopher J. McDougle, MD Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral Hospital
More informationThe Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD
The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD Damon Korb, MD Behavioral and Developmental Pediatrician Director of the Center for Developing Minds Los Gatos,
More informationManaging the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center
Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Abstract: The majority of boys and many girls with fragile X
More informationAttention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6
in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationCreating Partnerships. Laine Young-Walker, MD
Creating Partnerships Laine Young-Walker, MD Psychiatry is the medical specialty devoted to the study, diagnosis, treatment and prevention of mental disorders. Medical school >>>four years of residency
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationASD Autism Spectrum Disorder
Psychopharmacology and Autism Spectrum Disorder Bennett L. Leventhal, MD Professor Department of Psychiatry University of California, San Francisco Sources of Research Support NIH Simons Foundation Janssen
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationPharmacological management in children and adolescents with pervasive developmental disorder
Pharmacological management in children and adolescents with pervasive developmental disorder Min Sung, Daniel S. S. Fung, Yiming Cai, Yoon Phaik Ooi Objective: Pervasive developmental disorder (PDD) is
More informationPediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016
Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Good psychopharmacology depends on Proper use of safe and effective meds Treatment of other obvious factors (e.g., medical conditions, toxic
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More information2013 Virtual AD/HD Conference 1
Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com
More informationThe Use of ADHD Medication in the Pediatric Population
The Use of ADHD Medication in the Pediatric Population Shirin Madzhidova, PharmD Pediatric Pharmacotherapy Fellow Nova Southeastern University Objectives Discuss the importance of treatment with medications
More informationChild & Adolescent Psychiatry (a brief overview)
Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More information11/11/2018. The ABCs of Medication Management for Autism Spectrum Disorder. ABC Logging (FBA) First. ABC Logging HOW TO COMPLEMENT BEHAVIORAL THERAPY
The ABCs of Medication Management for Autism Spectrum Disorder OR HOW TO COMPLEMENT BEHAVIORAL THERAPY ABC Logging (FBA) First We need to know what, when, where and why behaviors happen. Antecedent: What
More informationAAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More informationBehavioral Health. Behavioral Health. Prescribing Guidelines
Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationUsing Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University
Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal Alan Poling, Ph.D., BCBA-D Western Michigan University In a 2010 study of 60,641 children Mandell et al. found that: 56%
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationMedication management in children and youth with ASD
Medication management in children and youth with ASD Evdokia Anagnostou, MD Clinician Scientist, Bloorview Research Institute Assistant Professor, Department of Pediatrics University of Toronto Disclosures
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,
More informationMedications, By Class, in TBI
Medications, By Class, in TBI Generic/Brand Name Drawback Advantage Mood Stabilizers (anti-seizure medications) Carbamazepine (Carbatrol ) (Equetro ) (Tegretol ) Gabapentin (Neurontin ) Lamotrigine (Lamictal
More informationThe Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders
The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders Charles Cartwright, M.D Director: YAI Autism Center March 2013 Autism Spectrum Defined by the
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationRole of ADHD medication in children with autism spectrum disorder. Pieter Hoekstra University of Groningen, Netherlands
Role of ADHD medication in children with autism spectrum disorder Pieter Hoekstra University of Groningen, Netherlands Symptoms of ADHD are highly prevalent in children with ASD Two independent chart reviews
More information3/6/2009. Disclosure
Recent Advances in the Psychopharmacologic Treatment of Individuals with Developmental Disabilities Antonio Hardan, M.D. Associate Professor of Psychiatry Director, Autism and Developmental Disabilities
More informationASD (hyperactivity) 3 rd LINE TREATMENT Initial liquid dose mg 2. - ADHD symptoms without sleep
Generic Name Label Name Dosing by Disorder RITALIN, RITALIN LA, CONCERTA, METADATE ER, 2 ND LINE TREATMENT 2 ND LINE TREATMENT METADATE CD, MPH ER, Initial liquid dose 1-5 mg 1,2 Initial liquid dose 1-5mg
More informationTRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY
TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient
More informationCriteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents
Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents DRUG NAME INDICATIONS / ACCEPTABLE USES PRIOR STIMULANT/ADHD DRUGS Daytrana (methylphenidate) ADHD
More informationA Primer on Psychotropic Medications. Michael Flaum, MD
The Iowa Mental Health System and Employment for Individuals with Psychiatric Conditions Iowa Vocational Rehabilitation Services Conference Des Moines, IA, September 18, 2006 A Primer on Psychotropic Medications
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationPsychopharmacology: An Overview
Psychopharmacology: An Overview John Tanquary, M.D. Clinical Assistant Professor Department of Psychiatry Upstate Medical University Psychpharmacology Consultant Le Moyne College Syracuse University Financial
More informationMental Health Intake Form
38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.
More informationHappy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
More informationMental Health Intake Form
Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )
More informationThings You Might Not Know About Psychotropic Medications But Wish You Did
Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and
More informationAn Overview on the Use of Psychotropic Medications
An Overview on the Use of Psychotropic Medications Marilyn B. Benoit, M.D. Chief Clinical Officer SVP, Clinical & Professional Affairs Classes of Medications Antidepressants Anti-anxiety Mood stabilizers
More informationAtomoxetine. Open study showed 60% response of inattention and hyperactivity with a few much worse (Jou et al 2005)
Atomoxetine Open study showed 60% response of inattention and hyperactivity with a few much worse (Jou et al 2005) Buspirone Case reports (McCormick 1997, Hillbrand and Scott 1995,Realmuto et al 1989,
More informationDevelopmental Disorders
Pharmacology of Pervasive Developmental Disorders W. David Lohr, M.D. Assistant Professor Child Psychiatry Bingham Child Guidance Center University of Louisville School of Medicine 502-852-1065 wdlohr01@louisville.edu
More informationPsychotropic Medications in Children and Adolescents: Guide for Use and Monitoring
Psychotropic Medications in Children and Adolescents: Guide for Use and This document was developed by Community Care of North Carolina with the assistance of the Medication Management Workgroup of the
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationEvidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center
Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to
More informationPaediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK).
Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Childhood pharmacokinetics Children have greater hepatic capacity More glomerular filtration Less fatty tissue Less ability to store
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationADHD and. Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry
ADHD and Beyond Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry Overview Use of medications in children How do medications work in the brain? Risperdal?
More informationDealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationWe ll Be Discussing. Pregnancy 4/24/2013
Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free monthly e-newsletter? We ll Be Discussing The safety and efficacy track
More informationBehavior Management & Psychopharmacology James Coplan, MD, Session Page 1. Disclosures. Behavior. Internalizing Behavior.
Session Number: 5528 Behavior management and psychopharmacology in children with autistic spectrum disorders James Coplan, MD Neurodevelopmental Pediatrics of the Main Line Rosemont, PA info@drcoplan.com
More informationCONTRAINDICATIONS TABLE
CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis
More informationHumberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor
The Carter Jenkins Center presents 1 Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor Emeritus of Psychiatry
More informationIntroductory discussion
Billina R. Shaw, MD Assistant Professor University of Maryland School of Medicine Department of Psychiatry Division of Child and Adolescent Psychiatry Introductory discussion Prescribing trends in foster
More informationExpected Outcomes. Assumptions. Borderline Personality Disorder: Pharmacologic Intervention
Borderline Personality Disorder: Pharmacologic Intervention Barbara J. Limandri, DNSc, APRN, BC Associate Professor Linfield College School of Nursing PMHNP Portland Dialectical Behavior Therapy Program
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More information8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation
Managing Psychiatric Conditions in Primary Care Beyond the Basics Source: US National Library of Medicine, Images from the History of Medicine Luis Berrios, DNP, MHA, ANP, PMHNP Internal Medicine & Primary
More informationmed ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.
med ed Dr. Andrea Murphy, Assistant Professor, School of Nursing, Dalhousie University; Research Associate, Sun Life Financial Chair in Adolescent Mental Health Dr. David Gardner, Associate Professor,
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More information3/19/18. Medications Used In the Mental Health Care of Children. General Pediatric Psychopharmacology Overview
Medications Used In the Mental Health Care of Children American Academy of Pediatrics Critical Issues in School Health March 22 nd 2018 Jennifer Zajac, D.O. Saachi Tarr, M.D. Vanessa Katon, D.O. Institute
More informationPL CE LIVE February 2011 Forum
February 2011 PL CE LIVE Kristin W. Weitzel, Pharm.D., CDE, FAPhA Associate Editor and Director of Editorial Projects Pharmacist s Letter/Prescriber s Letter Atypical Antipsychotics Atypical Antipsychotics
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationBob Klaehn, M.D. Bob Klaehn, M.D. October 3, /30/14
Bob Klaehn, M.D. October 3, 2014 1 Bob Klaehn, M.D. Medical Director, Arizona Division of Developmental Disabilities since 2001 Faculty, MIHS Child Psychiatry Residency Program Child Psychiatrist, District
More informationTourette Syndrome. Biological Basis, Clinical Symptoms, Treatment. Drake D. Duane, MS, MD
Tourette Syndrome Biological Basis, Clinical Symptoms, Treatment Drake D. Duane, MS, MD Director, Institute for Developmental Behavioral Neurology Adjunct Professor, Arizona State University Scottsdale/Tempe,
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationAD/HD is a mental disorder, and it often lasts from
short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.
More informationPresentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationUniversity of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 5 February History of stimulant treatment
Pharmacological Treatment of Attention Deficit Hyperactivity Disorder and its comorbidities Steven R. Pliszka, M.D. Professor and Vice Chair Chief, Division of Child and Adolescent Psychiatry Department
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More information9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationWelcome and thank you for choosing University of Florida Physicians!
DEPARTMENT OF PSYCHIATRY Tuesday, Division of March Child and 14, Adolescent 2017 Psychiatry 8491 NW 39 th Ave. Gainesville, FL 32606 Phone: 352-265-4357 Fax: 352-627-4163 Welcome and thank you for choosing
More information